PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35165101-1	2022	PURPOSE: Praluzatamab ravtansine (CX-2009) is a conditionally activated Probody  drug conjugate (PDC) comprising an anti-CD166 monoclonal antibody conjugated to DM4, with a protease-cleavable linker and a peptide mask that limits target engagement in normal tissue and circulation.	Maytansine	161-164	activated leukocyte cell adhesion molecule	Homo sapiens	121-126